• Cardiol amended its exclusive supply agreement with Noramco to fund raw materials for 700 kg of API production.
• Buyer to pay Noramco $1.2 million on Sept. 15, 2019, then $1.2 million by Nov. 30, 2019.
• Raw-material payments will be credited against future API purchases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiol Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-106836), on September 11, 2026, and is solely responsible for the information contained therein.